Takeda Reports FY2017 Full Year Results and Issues FY2018 Guidance

OSAKA, Japan–(BUSINESS WIRE)–May 14, 2018–Takeda Pharmaceutical Company Limited (TOKYO:4502): Underlying Revenue growth +5.5% led by Takeda’s Growth Drivers Underlying Revenue grew +5.5%, with Takeda’s Growth Drivers (Gastroenterology, Oncology …
( read original story …)


Related Post

The Luxurious Way to Experience Tokyo's Cherr...
views 226
Palace Hotel Tokyo’s Blossoming Tokyo packag...
Perfect day for Kenya as Kipsang wins Tokyo Marath...
views 272
Tokyo (AFP) - Kenya's Wilson Kipsang stormed to vi...
Japan hit by earthquake, Fukushima said to be unaf...
views 215
An earthquake of magnitude 5.6 has struck near the...
Japan might push through TPP without Canada
views 107
Japan's top diplomat in Western Canada is urging B...
Toshiba off Tokyo bourse’s special watchlist...
views 117
the conglomerate's domestic nuclear business is al...
Joy Billiards Takes Chinese 8-Ball To Vegas and Os...
views 269
Players can check out the Joy Billiards booth for ...
Tokyo Film Fest to Roll With a Comic Book Adaptati...
views 113
So, it would seem only apt that the 30th edition o...
Culturally sensitive version of The Mikado leaves ...
views 31
The Mikado productions commonly include actors in ...
Trump in Japan at start of 12-day Asian trip
views 125
US President Donald Trump ramped up his tough rhet...
Japan's whale kill disappoints New Zealand
views 194
New Zealand will express its "significant disappoi...